ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,987.37
0.30%
Dow Jones
44,736.57
0.99%
US Dollar vs MXN
20.59603
0.17%
Brent Oil
72.565
-0.06%
Bitcoin
94,707.98
1.74%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) Noticias

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:PVCT
FechaHoraFuenteTítuloSímboloCompañía
25/11/202416:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202407:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/11/202414:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/08/202418:23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/07/202415:07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/06/202405:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202409:54Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/05/202412:56Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/06/202308:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/06/202317:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202314:19Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202313:42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202315:53Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/05/202312:59Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/202313:43Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/03/202308:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/12/202207:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/10/202212:30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/03/202215:05Edgar (US Regulatory)Annual Report (10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
25/11/202012:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/201915:50Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201714:11Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201712:58Edgar (US Regulatory)(25-NSE)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/04/201716:17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/04/201716:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/03/201705:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/03/201715:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/03/201705:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
31/01/201705:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/01/201705:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Su Consulta Reciente

NYSE
MRK
Merck
CCOM
OILBRENT
Brent Oil
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
NYSE
AXP
American Express
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
XRPUSD
Ripple
COIN
DOGEUSD
Dogecoin
USOTC
BNPQY
BNP Paribas (QX)
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados